AI in healthcare: first global standards for clinical trials involving AI interventions

Artificial intelligence (AI) has the potential to transform healthcare as we know it. There have been dramatic announcements of AI solutions for almost every medical need including screening, triage, diagnosis, and treatment recommendation. The public interest, financial opportunities and enthusiastic coverage has meant that there are unusually strong drivers to accelerate the introduction and implementation … Continue reading “AI in healthcare: first global standards for clinical trials involving AI interventions”

Innovative COVID-19 cell therapy trial – in the researcher’s words

Research nurse Samantha Caddick and clinical trials coordinator Salma Kadiri, both working at UHB’s Heartlands Hospital in Birmingham, relive the moment they recruited the first patient on an innovative cell therapy trial for COVID-19. Their blog is part of the NIHR’s COVID-19 Research Voices series. We will never forget our first time entering the intensive … Continue reading “Innovative COVID-19 cell therapy trial – in the researcher’s words”

Tackling multimorbidity through collaboration

As populations age, multimorbidity becomes an increasingly pertinent issue for healthcare systems. A new action group from the ABPI-BHP partnership seeks to bring the NHS, academia and industry together to find new ways to address the problem. The Association’s Dr Sheuli Porkess and Professor Janet Lord from the University of Birmingham tell us more. Multimorbidity … Continue reading “Tackling multimorbidity through collaboration”

Everyday cyborgs: how should the law deal with implanted medical devices?

Attached and implanted technologies are now part of everyday life for many millions of people. Yet as the capabilities of these devices have advanced rapidly in recent years, lawmakers have struggled to keep pace. Professor Muireann Quigley at BHP founder-member the University of Birmingham believes that it is now more critical than ever that the law … Continue reading “Everyday cyborgs: how should the law deal with implanted medical devices?”

SARS-CoV-2 antibody ELISA test launched

In collaboration with scientists from across BHP, The Binding Site – a University of Birmingham spin-out – has released a quality IgG, IgA and IgM SARS-CoV-2 antibody ELISA test. Given the range of symptoms of coronavirus and the lack of distinguishing clinical features, understanding the infection prevalence is of key importance. Diagnostic tests for COVID-19 … Continue reading “SARS-CoV-2 antibody ELISA test launched”